Sarepta’s Medical Director, Clinical Development discusses the company’s upcoming ENVISION study for SRP-9001. Research & Clinical Trial Webinars,Webinars 2 years ago You may also like Webinar: Sarepta Therapeutics – Safety Update on ELEVIDYS in Non-Ambulatory Individuals Living with Duchenne 5 days ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta 1:14:53 Webinar: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne 2 weeks ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 59:44 Webinar: Steroids and Stress Dosing – Understanding the Updated PJ Nicholoff Steroid Protocol 3 weeks ago Care Webinars,Webinars emergency care,PJ's Protocol,steroids 01:06:15 Webinar: Discover the Power of Your Data – The Duchenne Registry 1 month ago Webinars The Duchenne Registry 1:20:43 Webinar: Sarepta Therapeutics – Duchenne Gene Therapy Update 2 months ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta 29:52 Webinar: Duchenne Newborn Screening – Next Steps Following ACHDNC Dissolution 2 months ago Webinars newborn screening 59:32 Webinar: Wave Life Sciences – Update on FORWARD-53 Study of WVE-N531 3 months ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 1:00:09 Webinar: Avidity Biosciences – Topline Data from EXPLORE44® Clinical Trial 3 months ago Research & Clinical Trial Webinars,Webinars AOC 1044,avidity biosciences,del-zota 123…27»Page 1 of 27